Copyrighted Image? DMCA | Foreign drug trials have become crucial to pharmaceutical companies looking for approval from the U.S. Food and Drug Administration to sell their products to Americans. Eighty percent of the drugs that the FDA reviews for approval now rely on some tests done on foreign soil, according to a 2010 report issued by the U.S. Health and Human Service's Office of Inspector General.
The same report included another startling figure: The FDA inspects fewer than 1 percent of foreign drug trial sites, a number slightly higher than the percentage of sites inspected in the U.S. "We have no idea what's going on in these clinical trials," said Dr. Carl Elliott, a professor at the Center for Bioethics at the University of Minnesota and author of "White Coat, Black Hat: Adventures on the Dark Side of Medicine." |
Read the rest of the story HERE:
At openchannel.msnbc.msn.com
At openchannel.msnbc.msn.com
